You have 9 free searches left this month | to do more
Showing 26 - 50 of
619 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients Without Metastasis
Recruiting
  • Prostate Cancer Patients
  • Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin
  • Qingdao, Shandong, China
  • +1 more
2020-10-19
Oct 19, 2020
S
CLAM Chemotherapy With PBSC Support for Relapsed Patients After Allogeneic Stem Cell Transplantation
Suspended
  • Leukemia
  • Shanghai, China
    Rui Jin Hospital, Department of Hematology
2021-11-23
Nov 23, 2021
U
Continuous Infusion Chemotherapy (CI-CLAM) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms - 2021
Terminated
  • Myeloid Neoplasm
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-01-05
Jan 5, 2022
U
Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms
Recruiting
  • Acute Biphenotypic Leukemia
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-02-18
Feb 18, 2022
R
Study Evaluating Efficacy and Safety of CPI-613 in Combination With HD Cytarabine and Mitoxantrone Compared to HD Cytarabine and Mitoxantrone and Control Sub-groups: MEC and FLAG in Older Patients With R/R AML - 2021
Terminated
  • Relapsed/Refractory Acute Myeloid Leukemia
  • CPI-613 + High Dose Cytarabine and Mitoxantrone
  • +3 more
  • Scottsdale, Arizona
  • +59 more
2021-11-01
Nov 1, 2021
N
A Phase Ib, Open-label, Multi-center Dose-finding Study of Oral Panobinostat (LBH589) in Combination With Ara-C and Mitoxantrone as Salvage Therapy for Refractory or Relapsed Acute Myeloid Leukemia - 2012
Completed
  • Acute Myeloid Leukemia
  • Paris Cedex 4, France
  • +5 more
2020-12-16
Dec 16, 2020
S
Biomarkers in Predicting Treatment Response to Sirolimus and Chemotherapy in Patients With High-Risk Acute Myeloid Leukemia
Recruiting
  • Recurrent Adult Acute Myeloid Leukemia
  • +2 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
2020-12-07
Dec 7, 2020
R
Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia
Withdrawn
  • Leukemia
  • recombinant interferon alfa
  • +7 more
  • Chicago, Illinois
  • +3 more
2021-10-06
Oct 6, 2021
M
Lintuzumab-Ac225 in Combination With Cladribine + Cytarabine + Filgastrim + Mitoxantrone (CLAG-M) for Relapsed/Refractory Acute Myeloid Leukemia
Recruiting
  • Acute Myeloid Leukemia
  • Lintuzumab-Ac-225 (Dose 1: 0.25 μCi/kg Ac-225 with 1.6 μg/kg lintuzumab)
  • +8 more
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
2021-05-14
May 14, 2021
N
Testing the Addition of an Anti-cancer Drug, M3814, to the Usual Treatment (Mitoxantrone, Etoposide, and Cytarabine) for Relapsed or Refractory Acute Myeloid Leukemia
Recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Duarte, California
  • +6 more
2022-03-31
Mar 31, 2022
K
Phase II Study of the Combination of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin (MEGO) for Patients With Acute Myeloid Leukemia Refractory to Initial Standard Induction Therapy
Recruiting
  • Acute Myeloid Leukemia
  • mitoxantrone + etoposide + gemtuzumab ozogamicin
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
2022-02-09
Feb 9, 2022
S
Combination Chemotherapy and Rituximab With Pegfilgrastim Followed by Rituximab, in Large B-Cell Non-Hodgkin's Lymphoma - 2010
Completed
Has Results
  • Non-Hodgkins Lymphoma
  • Fort Myers, Florida
  • +1 more
2022-02-21
Feb 21, 2022
C
A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced HER2 Negative Breast Cancer
Recruiting
  • Breast Cancer
  • Mitoxantrone Hydrochloride Liposome Injection
  • Hefei, Anhui, China
  • +28 more
2021-06-15
Jun 15, 2021
U
Selinexor With Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia - 2019
Completed
  • Acute Myeloid Leukemia
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
2020-04-06
Apr 6, 2020
M
Rituximab, Fludarabine, Mitoxantrone, Dexamethasone (R-FND) Plus Zevalin for High-Risk Follicular Lymphoma - 2021
Completed
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-02-15
Feb 15, 2021
U
Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia - 2019
Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +16 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
2020-05-13
May 13, 2020
M
Mitoxantrone, Etoposide, and Cytarabine (MEC) Plus Lenalidomide for Relapsed or Refractory Acute Myeloid Leukemia
Active, not recruiting
Has Results
  • AML
  • Boston, Massachusetts
  • +2 more
2021-01-13
Jan 13, 2021
U
Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma - 2013
Completed
  • Lymphoma
  • Lyon, France
    Centre Leon Berard
2021-02-19
Feb 19, 2021
F
Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes - 2018
Completed
Has Results
  • Acute Biphenotypic Leukemia
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2019-12-26
Dec 26, 2019
M
Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients - 2017
Completed
Has Results
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2020-10-22
Oct 22, 2020
S
A Study for Improving the Outcome of Childhood Acute Promyeloid Leukemia
Enrolling by invitation
  • Childhood Acute Promyelocytic Leukemia
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-Sen University
2021-09-22
Sep 22, 2021
M
Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute Leukemias - 2011
Terminated
  • Leukemia
  • Hershey, Pennsylvania
    Penn State Hershey Cancer Institute
2019-07-22
Jul 22, 2019
I
The Efficiency of CAMS (Chinese Academy of Medical Sciences)-2016 Trial for Pediatric Acute Myeloid Leukemia
Recruiting
  • Acute Myeloid Leukemia
  • Tianjin, Tianjin, China
    InstituteHBDH
2021-02-02
Feb 2, 2021
D
A Study of Intravenous EEDVsMit in Children With Recurrent / Refractory Solid or CNS Tumours Expressing EGFR - 2021
Terminated
  • Solid Tumours
  • CNS Tumours
  • Mitoxantrone packaged EDV (EnGeneIC Delivery Vehicle)
  • Randwick, New South Wales, Australia
  • +1 more
2022-01-30
Jan 30, 2022
F
Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDS - 2018
Completed
Has Results
  • Mixed Phenotype Acute Leukemia
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2020-02-21
Feb 21, 2020